Effect of Colchicine on Coronary Reperfusion in Patients With Acute Coronary Syndrome
Status:
Not yet recruiting
Trial end date:
2023-10-30
Target enrollment:
Participant gender:
Summary
This randomized clinical trial will determine the treatment effect of colchicine (1.5 mg
loading dose and 0.5 mg daily thereafter) for 6 weeks on microvascular coronary reperfusion
and infarct size in patients with acute coronary syndrome.
Phase:
Phase 2
Details
Lead Sponsor:
Pontificia Universidad Catolica de Chile
Collaborator:
Fondo Nacional de Desarrollo Científico y Tecnológico, Chile